[CYCC] QoQ Quarter Result on 31-Mar-2016 [#Q1]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
13-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- 9.87%
YoY- 38.09%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Revenue 277 205 222 139 424 715 296 -4.30%
PBT -3,249 -3,400 -3,591 -3,534 -3,872 -3,187 -3,752 -9.11%
Tax -409 -454 -626 -493 -498 -478 -405 0.65%
NP -2,839 -2,946 -2,965 -3,041 -3,374 -2,709 -3,347 -10.34%
Tax Rate - - - - - - - -
Total Cost 3,116 3,151 3,187 3,180 3,798 3,424 3,643 -9.85%
Ratio Analysis
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
NP Margin -1,024.91 -1,437.07 -1,335.59 -2,187.77 -795.75 -378.88 -1,130.74 -6.31%
Per Share
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
EPS -13.34 -16.96 -19.77 -20.51 -23.15 -18.75 -23.36 -31.05%
EPS Diluted -13.34 -16.96 -19.77 -20.51 -23.15 -18.75 -23.36 -31.05%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.